UPMC Vascular Surgeon Wins Award to develop non surgical therapies to unblock arteries


Vascular Cures and the Society of Vascular Surgery named Ryan McEnaney, MD, University of Pittsburgh Medical Center, as the 2016 Wylie Scholar. The Wylie Scholar Program, now in its 20th year, awards three-year $150,000 research grants to young vascular surgeon-scientists to pursue innovative basic or clinical research projects. It is one of the most important grants for early-stage scientists as it launches their ability to successfully compete for NIH and other grants. Dr. McEnaney is the 19th Wylie Scholar and the 4th Scholar from UMPC. Dr. McEnaney’s research may ultimately lead to the development of medical therapies to unblock arteries for patients for whom surgical procedures are not an option. Dr. McEnaney received his medical degree from the Saint Louis University School of Medicine and completed his residency at UPMC, where he served as administrative chief resident in vascular surgery. He is board certified in vascular surgery. Dr. McEnaney's surgical interests include peripheral vascular disease, aortic aneurysms, venous diseases, and vascular access. His scientific research focuses on the molecular biology and biochemistry of vascular adaptation to occlusive disease. To learn more about Dr. McEnaney's work click here.


Project Voice Launch


Vascular Cures, the only national non-profit focused on transforming research into vascular health, announced in March 2016 the launch of its latest initiative, Project Voice.  A pilot study at Wake Forest University Baptist Medical Center in North Carolina is being led by Matthew Corriere, MD, Associate Professor of Surgery, to help patients with peripheral arterial disease (PAD), a disease that afflicts more than 10 million Americans. Project Voice enables unique collaborations across the spectrum of vascular care. It brings the latest in digital health technology to the unique needs of the vascular health community leading to improved patient engagement­­, more powerful research and a communication bridge between patients and doctors. Find out more here.


Vascular Cures Boosts Board Strength with UC Davis Vice Chancellor and UnitedHealthcare Executive

Julie Freischlag headshot

Vascular Cures, the only national non-profit focused on transforming research and health for diseases outside the heart, announced the addition of two new board members: Julie Freischlag, MD, Vice Chancellor for Human Health Sciences and Dean of the School of Medicine at UC Davis and Lori C. McDougal, a former member of the UnitedHealthcare (UHG) executive leadership team and CEO of the UHG Military and Veterans business segment.

"Dr. Freischlag and Ms. McDougal bring unique perspectives on the challenges of health care in the 21st century. Their perspectives will help guide our strategic initiatives to empower patients while supporting life-saving research," said Wendy Hitchcock, Vascular Cures CEO. "As a leader of a major academic health system, Dr. Freischlag knows the opportunities to improve patient outcomes through research, technology and innovative care. And as a senior executive at one of the country's largest health insurers, Ms. McDougal has been at the forefront of developing new models for care delivery to improve health while addressing skyrocketing costs. We are honored to have them join the Vascular Cures' leadership team."

Ms. McDougal is an independent Board member who has engineered transformational 

Lori McDougal Picture 2market expansion across government, commercial and international sectors. Her industry thought leadership helps to align health policy, academic research and market trends to create clarity of insight. As previous CEO and founder of UnitedHealthcare Military and Veterans, she created a $4.1 billion dollar division serving more than 2.9 million military beneficiaries. Dr. Freischlag oversees UC Davis Health System's academic, research and clinical programs including the Schools of Medicine and Nursing, the 1,000-member physician practice group, and UC Davis Medical Center. She is particularly excited about Vascular Cures' new digital health engagement platform, Project Voice, as it is the first unified platform for patient-engagement and patient-reported outcomes research for vascular disease. Her experience as a vascular surgeon showed her the need for such a program to catalyze greater collaboration between patients, researchers, providers and industry. Read the press release here.


Washington University Vascular Surgeon Wins Award to Improve Limb Preservation in Diabetic Patients


Vascular Cures has named Mohamed Zayed, MD, PhD, at Washington University School of Medicine, St. Louis, Missouri, as its 2015 Wylie Scholar in Academic Vascular Surgery. The $150,000 multi-year grant, co-sponsored by the Society for Vascular Surgery, was awarded to support Dr. Zayed's research on the role of phospholipids in the progression of peripheral arterial disease in the setting of diabetes. Individuals with chronic diabetes – approximately 20 million Americans, develop a unique pattern of diffuse lower leg peripheral arterial disease, which dramatically increases their risk for poor tissue healing and higher rates of major lower extremity amputations. It is presumed that accelerated arterial plaque development (atheroprogression) and impaired arterial collateral formation (arteriogenesis) contribute to this process, but the molecular processes that lead to this are not yet understood. Dr. Zayed's current research will provide the impetus for future translational studies that aim to improve peripheral arterial patency and limb preservation in diabetic patients. To learn more about Dr. Zayed's work click here.

Vascular Cures' Wylie Scholar Program provides financial assistance to outstanding surgeons at the early stage of their careers to help them develop as academic vascular surgeon-scientists. Vascular Cures has advanced breakthrough research since 1982.


Circulate! 2015


Circulate! is Vascular Cures annual dinner took place on Saturday, October 10, 2015 at the Olympic Club in San  Francisco, CA. The goal of the event is to raise awareness about vascular disease and to raise much needed funds to find better treatments for vascular disease. The festivities include silent and live auctions, exquisite wines and dinner, and presentations by keynote speakers, patients, and innovators in the field of vascular health. This year's keynote speaker is Jim Craig, former American ice hockey player who is most notable for being the goaltender for the 1980 U.S. Olympic hockey team that won the Olympic gold medal at the Lake Placid Winter Games; one of the most extraordinary and memorable sports victories of all time! The personal loss of his father years later to an undetected abdominal aneurysm (AAA), has led Jim to champion the cause of early detection of vascular disease. While an estimated 15,000 people each year die from AAA in the US, the good news is that the condition is almost always treatable if detected early. To RSVP click hereFor more information please call (650) 368-6022 or email: This email address is being protected from spambots. You need JavaScript enabled to view it..


Page 1 of 4

<< Start < Prev 1 2 3 4 Next > End >>